HLX05 drug page Clinical trials

Trials with HLX05

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
322Planned patients

Showing 1–1 of 1

Phase I PK Comparison of HLX05 vs. Erbitux® in Healthy Chinese Males: Safety, Immunogenicity, and Pharmacokinetics
Ongoing, not recruiting Phase 1 322 patients NCT06980454

This is a randomized, single intravenous dose, parallel study to compare the PK characteristics, safety, tolerability, and immunogenicity of HLX05 vs. Erbitux® (US-, EU-, and CN-sourced) in healthy adult male Chinese subjects.

China Jun 2025 – Dec 2025 Interventional
Combined with: Cetuximab